Dose-Tapering of TNF Inhibitors in Daily Rheumatology Practice Enables the Maintenance of Clinical Efficacy While Improving Cost-Effectiveness

Journal of Pharmacovigilance
doi 10.4172/2329-6887.1000172
Full Text
Abstract

Available in full text

Date
Authors
Publisher

OMICS Publishing Group

Related search

Long-Term Efficacy of Etanercept for Plaque-Type Psoriasis and Estimated Cost in Daily Clinical Practice

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Adalimumab Dose Tapering in Psoriasis: Predictive Factors for Maintenance of Complete Clearance

Acta Dermato-Venereologica
DermatologyMedicine
2017English

Cost Effectiveness of TNF-αInhibitors in Rheumatoid Arthritis

International Journal of Inflammation
AllergyImmunology
2013English

Effectiveness in Clinical Practice Versus Efficacy of Dipeptidyl Peptidase-4 Inhibitors in Clinical Trials for Type 2 Diabetes: Protocol for Systematic Review

BMJ Open
Medicine
2019English

Evaluation of the Efficacy and Safety of Single Dose Iron Infusion in Clinical Practice

Gut
Gastroenterology
2013English

Systematic Reviews of the Clinical Effectiveness and Cost-Effectiveness of Proton Pump Inhibitors in Acute Upper Gastrointestinal Bleeding

Health Technology Assessment
MedicineHealth Policy
2007English

Systematic Appraisal of the American College of Rheumatology Clinical Practice Guidelines

ACR Open Rheumatology
2019English

Cost-Effectiveness of Abatacept, Tocilizumab and TNF-inhibitors Compared With Rituximab as Second-Line Biologic Drug in Rheumatoid Arthritis

PLoS ONE
Multidisciplinary
2019English

Psy83 - Impact of Dose Escalation on Average Cost and Cost-Effectiveness of Anti-TNF and Ustekinumab in the Treatment of Moderate-To-Severe Plaque Psoriasis in Sweden

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy